The global market for Wearable Drug Delivery Systems was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Drug Delivery Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Wearable Drug Delivery Systems by region & country, by Type, and by Application.
The Wearable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Drug Delivery Systems.
麻豆原创 Segmentation
By Company
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
Segment by Type:
Electronical Drug Delivery Devices
Mechanical Drug Delivery Devices
Segment by Application
Hospital
Clinic
麻豆原创 Care
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Wearable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Wearable Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Wearable Drug Delivery Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Wearable Drug Delivery Systems Product Introduction
1.2 Global Wearable Drug Delivery Systems 麻豆原创 Size Forecast
1.2.1 Global Wearable Drug Delivery Systems Sales Value (2019-2030)
1.2.2 Global Wearable Drug Delivery Systems Sales Volume (2019-2030)
1.2.3 Global Wearable Drug Delivery Systems Sales Price (2019-2030)
1.3 Wearable Drug Delivery Systems 麻豆原创 Trends & Drivers
1.3.1 Wearable Drug Delivery Systems Industry Trends
1.3.2 Wearable Drug Delivery Systems 麻豆原创 Drivers & Opportunity
1.3.3 Wearable Drug Delivery Systems 麻豆原创 Challenges
1.3.4 Wearable Drug Delivery Systems 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Wearable Drug Delivery Systems Players Revenue Ranking (2023)
2.2 Global Wearable Drug Delivery Systems Revenue by Company (2019-2024)
2.3 Global Wearable Drug Delivery Systems Players Sales Volume Ranking (2023)
2.4 Global Wearable Drug Delivery Systems Sales Volume by Company Players (2019-2024)
2.5 Global Wearable Drug Delivery Systems Average Price by Company (2019-2024)
2.6 Key Manufacturers Wearable Drug Delivery Systems Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Wearable Drug Delivery Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Wearable Drug Delivery Systems
2.9 Wearable Drug Delivery Systems 麻豆原创 Competitive Analysis
2.9.1 Wearable Drug Delivery Systems 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Wearable Drug Delivery Systems Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Drug Delivery Systems as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Electronical Drug Delivery Devices
3.1.2 Mechanical Drug Delivery Devices
3.2 Global Wearable Drug Delivery Systems Sales Value by Type
3.2.1 Global Wearable Drug Delivery Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Wearable Drug Delivery Systems Sales Value, by Type (2019-2030)
3.2.3 Global Wearable Drug Delivery Systems Sales Value, by Type (%) (2019-2030)
3.3 Global Wearable Drug Delivery Systems Sales Volume by Type
3.3.1 Global Wearable Drug Delivery Systems Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Wearable Drug Delivery Systems Sales Volume, by Type (2019-2030)
3.3.3 Global Wearable Drug Delivery Systems Sales Volume, by Type (%) (2019-2030)
3.4 Global Wearable Drug Delivery Systems Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 麻豆原创 Care
4.1.4 Others
4.2 Global Wearable Drug Delivery Systems Sales Value by Application
4.2.1 Global Wearable Drug Delivery Systems Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Wearable Drug Delivery Systems Sales Value, by Application (2019-2030)
4.2.3 Global Wearable Drug Delivery Systems Sales Value, by Application (%) (2019-2030)
4.3 Global Wearable Drug Delivery Systems Sales Volume by Application
4.3.1 Global Wearable Drug Delivery Systems Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Wearable Drug Delivery Systems Sales Volume, by Application (2019-2030)
4.3.3 Global Wearable Drug Delivery Systems Sales Volume, by Application (%) (2019-2030)
4.4 Global Wearable Drug Delivery Systems Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Wearable Drug Delivery Systems Sales Value by Region
5.1.1 Global Wearable Drug Delivery Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Wearable Drug Delivery Systems Sales Value by Region (2019-2024)
5.1.3 Global Wearable Drug Delivery Systems Sales Value by Region (2025-2030)
5.1.4 Global Wearable Drug Delivery Systems Sales Value by Region (%), (2019-2030)
5.2 Global Wearable Drug Delivery Systems Sales Volume by Region
5.2.1 Global Wearable Drug Delivery Systems Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Wearable Drug Delivery Systems Sales Volume by Region (2019-2024)
5.2.3 Global Wearable Drug Delivery Systems Sales Volume by Region (2025-2030)
5.2.4 Global Wearable Drug Delivery Systems Sales Volume by Region (%), (2019-2030)
5.3 Global Wearable Drug Delivery Systems Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Wearable Drug Delivery Systems Sales Value, 2019-2030
5.4.2 North America Wearable Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Wearable Drug Delivery Systems Sales Value, 2019-2030
5.5.2 Europe Wearable Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Wearable Drug Delivery Systems Sales Value, 2019-2030
5.6.2 Asia Pacific Wearable Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Wearable Drug Delivery Systems Sales Value, 2019-2030
5.7.2 South America Wearable Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Wearable Drug Delivery Systems Sales Value, 2019-2030
5.8.2 Middle East & Africa Wearable Drug Delivery Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Wearable Drug Delivery Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Wearable Drug Delivery Systems Sales Value
6.2.1 Key Countries/Regions Wearable Drug Delivery Systems Sales Value, 2019-2030
6.2.2 Key Countries/Regions Wearable Drug Delivery Systems Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Wearable Drug Delivery Systems Sales Value, 2019-2030
6.3.2 United States Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Wearable Drug Delivery Systems Sales Value, 2019-2030
6.4.2 Europe Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Wearable Drug Delivery Systems Sales Value, 2019-2030
6.5.2 China Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Wearable Drug Delivery Systems Sales Value, 2019-2030
6.6.2 Japan Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Wearable Drug Delivery Systems Sales Value, 2019-2030
6.7.2 South Korea Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Wearable Drug Delivery Systems Sales Value, 2019-2030
6.8.2 Southeast Asia Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Wearable Drug Delivery Systems Sales Value, 2019-2030
6.9.2 India Wearable Drug Delivery Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India Wearable Drug Delivery Systems Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gerresheimer
7.1.1 Gerresheimer Company Information
7.1.2 Gerresheimer Introduction and Business Overview
7.1.3 Gerresheimer Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gerresheimer Wearable Drug Delivery Systems Product Offerings
7.1.5 Gerresheimer Recent Development
7.2 Owen Mumford
7.2.1 Owen Mumford Company Information
7.2.2 Owen Mumford Introduction and Business Overview
7.2.3 Owen Mumford Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Owen Mumford Wearable Drug Delivery Systems Product Offerings
7.2.5 Owen Mumford Recent Development
7.3 Sonceboz
7.3.1 Sonceboz Company Information
7.3.2 Sonceboz Introduction and Business Overview
7.3.3 Sonceboz Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sonceboz Wearable Drug Delivery Systems Product Offerings
7.3.5 Sonceboz Recent Development
7.4 United Therapeutics
7.4.1 United Therapeutics Company Information
7.4.2 United Therapeutics Introduction and Business Overview
7.4.3 United Therapeutics Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.4.4 United Therapeutics Wearable Drug Delivery Systems Product Offerings
7.4.5 United Therapeutics Recent Development
7.5 Ypsomed
7.5.1 Ypsomed Company Information
7.5.2 Ypsomed Introduction and Business Overview
7.5.3 Ypsomed Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ypsomed Wearable Drug Delivery Systems Product Offerings
7.5.5 Ypsomed Recent Development
7.6 Elcam Medical
7.6.1 Elcam Medical Company Information
7.6.2 Elcam Medical Introduction and Business Overview
7.6.3 Elcam Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Elcam Medical Wearable Drug Delivery Systems Product Offerings
7.6.5 Elcam Medical Recent Development
7.7 Enable Injections
7.7.1 Enable Injections Company Information
7.7.2 Enable Injections Introduction and Business Overview
7.7.3 Enable Injections Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Enable Injections Wearable Drug Delivery Systems Product Offerings
7.7.5 Enable Injections Recent Development
7.8 Unilife Corporation
7.8.1 Unilife Corporation Company Information
7.8.2 Unilife Corporation Introduction and Business Overview
7.8.3 Unilife Corporation Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Unilife Corporation Wearable Drug Delivery Systems Product Offerings
7.8.5 Unilife Corporation Recent Development
7.9 West Pharma
7.9.1 West Pharma Company Information
7.9.2 West Pharma Introduction and Business Overview
7.9.3 West Pharma Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.9.4 West Pharma Wearable Drug Delivery Systems Product Offerings
7.9.5 West Pharma Recent Development
7.10 Eitan Medical
7.10.1 Eitan Medical Company Information
7.10.2 Eitan Medical Introduction and Business Overview
7.10.3 Eitan Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Eitan Medical Wearable Drug Delivery Systems Product Offerings
7.10.5 Eitan Medical Recent Development
7.11 BD Medical
7.11.1 BD Medical Company Information
7.11.2 BD Medical Introduction and Business Overview
7.11.3 BD Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.11.4 BD Medical Wearable Drug Delivery Systems Product Offerings
7.11.5 BD Medical Recent Development
7.12 Noble International
7.12.1 Noble International Company Information
7.12.2 Noble International Introduction and Business Overview
7.12.3 Noble International Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Noble International Wearable Drug Delivery Systems Product Offerings
7.12.5 Noble International Recent Development
7.13 Insulet
7.13.1 Insulet Company Information
7.13.2 Insulet Introduction and Business Overview
7.13.3 Insulet Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Insulet Wearable Drug Delivery Systems Product Offerings
7.13.5 Insulet Recent Development
7.14 Amgen
7.14.1 Amgen Company Information
7.14.2 Amgen Introduction and Business Overview
7.14.3 Amgen Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Amgen Wearable Drug Delivery Systems Product Offerings
7.14.5 Amgen Recent Development
7.15 Roche
7.15.1 Roche Company Information
7.15.2 Roche Introduction and Business Overview
7.15.3 Roche Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Roche Wearable Drug Delivery Systems Product Offerings
7.15.5 Roche Recent Development
7.16 CeQur
7.16.1 CeQur Company Information
7.16.2 CeQur Introduction and Business Overview
7.16.3 CeQur Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.16.4 CeQur Wearable Drug Delivery Systems Product Offerings
7.16.5 CeQur Recent Development
7.17 ScPharmaceuticals
7.17.1 ScPharmaceuticals Company Information
7.17.2 ScPharmaceuticals Introduction and Business Overview
7.17.3 ScPharmaceuticals Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
7.17.4 ScPharmaceuticals Wearable Drug Delivery Systems Product Offerings
7.17.5 ScPharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Wearable Drug Delivery Systems Industrial Chain
8.2 Wearable Drug Delivery Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Wearable Drug Delivery Systems Sales Model
8.5.2 Sales Channel
8.5.3 Wearable Drug Delivery Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
听
听
*If Applicable.
